Objectives: To evaluate the internal consistency, validity, responsiveness, and minimal important difference of the Functional Status Score for the ICU, a physical function measure designed for the ICU. Design: Clinimetric analysis. Settings: Five international datasets from the United States, Australia, and Brazil. Patients: Eight hundred nineteen ICU patients. Intervention: None. Measurements and Main Results: Clinimetric analyses were initially conducted separately for each data source and time point to examine generalizability of findings, with pooled analyses performed thereafter to increase power of analyses. The Functional Status Score for the ICU demonstrated good to excellent internal consistency. There was good convergent and discriminant validity, with significant and positive correlations (r = 0.30-0.95) between Functional Status Score for the ICU and other physical function measures, and generally weaker correlations with nonphysical measures (|r| = 0.01-0.70). Known group validity was demonstrated by significantly higher Functional Status Score for the ICU scores among patients without ICU-acquired weakness (Medical Research Council sum score, ≥ 48 vs < 48) and with hospital discharge to home (vs healthcare facility). Functional Status Score for the ICU at ICU discharge predicted post-ICU hospital length of stay and discharge location. Responsiveness was supported via increased Functional Status Score for the ICU scores with improvements in muscle strength. Distribution-based methods indicated a minimal important difference of 2.0-5.0. Conclusions: The Functional Status Score for the ICU has good internal consistency and is a valid and responsive measure of physical function for ICU patients. The estimated minimal important difference can be used in sample size calculations and in interpreting studies comparing the physical function of groups of ICU patients. (Crit Care Med 2016; 44:e1155-e1164) 
Saint-Clair G. B. Neto, PT 6, 7, 8 ; Jose A. A. Neto, MSc, PT 7, 8 ; Vinicius Z. M. da Silva, MSc, PT 9, 10 C ritically ill patients frequently experience long-lasting impairments in physical functioning after discharge from the ICU (1) (2) (3) (4) (5) . There is a growing body of research aimed at evaluating ICU-based interventions that may reduce these impairments and growing interest in measures of physical function for critically ill adults (6) (7) (8) .
The Functional Status Score for the ICU (FSS-ICU) is a physical function measure specifically designed for the ICU that has not had comprehensive evaluation of its clinimetric performance (9, 10) . The FSS-ICU includes five functional tasks (rolling, transfer from spine to sit, sitting at the edge of bed, transfer from sit to stand, and walking). Each task is evaluated using an eight-point ordinal scale ranging from 0 (not able to perform) to 7 (complete independence; Web Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ B952; for example, scale, instrument, and scoring details are available at http:www.ImproveLTO.com). The total FSS-ICU score ranges from 0 to 35, with higher scores indicating better physical functioning.
Our objective was to evaluate the internal consistency, construct and predictive validity, responsiveness, and minimum important difference (MID) of the FSS-ICU in ICU patients across different in-patient assessment time points and across international ICU settings.
METHODS
This analysis was conducted in accordance with the consensus-based standards for the selection of health measurement instruments guideline for evaluating the measurement properties of instruments (11) .
Study Design
We performed a clinimetric evaluation of the FSS-ICU using data from five international datasets: two from the United States (9, 12) , one from Australia (13, 14) , and two from Brazil. All datasets were approved by the appropriate ethics review boards, and where required, informed consent was obtained.
The USA-Kho dataset (n = 34) was a randomized pilot trial of neuromuscular electrical stimulation (NMES) that enrolled patients requiring mechanical ventilation for less than or equal to 4 days in three medical and surgical ICUs in an academic medical center in Baltimore, MD, between 2008 and 2013 (15, 16) . The randomized intervention of NMES versus a sham control group did not have a significant effect on the FSS-ICU score, so intervention and control groups were pooled for this analysis.
The USA-Needham dataset (n = 59) was a quality improvement (QI) project that enrolled patients requiring mechanical ventilation for more than or equal to 4 days in a single medical ICU at an academic medical center in Baltimore, MD, during 2007 (9, 12) . This project used a structured QI framework to improve functional mobility via physical and occupational therapy. The QI versus pre-QI periods did not have a significant difference in the FSS-ICU score, so both periods were pooled for this analysis.
The Australia dataset (n = 66) included consecutive enrolled patients requiring mechanical ventilation for more than 48 hours in two mixed medical-surgical ICUs and received routine care in Melbourne, VIC, Australia, between 2012 and 2014 (13) .
The Brazil-da Silva dataset (n = 99) included consecutive patients admitted in a single mixed (trauma, neurosurgical, and cardiovascular) ICU and received routine physical therapy (no intervention) in at a public hospital in Brasilia, Brazil, in 2014, using a Portuguese version of FSS-ICU developed with independent forward and backward language translation. The FSS-ICU data were collected as part of the routine care of physical therapy evaluation.
The Brazil-Neto dataset (n = 561) included consecutive patients more than or equal to 60 years old admitted in four ICUs (three medical-surgical and one surgical) and received routine physical therapy (no intervention) at a private hospital in Brasilia, Brazil, between 2013 and 2014, using a Portuguese version of FSS-ICU translated by the Brazilian investigators. The FSS-ICU data were collected as part of the routine care of physical therapy evaluation.
Study Measures
The FSS-ICU was evaluated prior to hospitalization (via proxy, evaluating the 2-mo period prior to hospitalization) and at ICU awakening, ICU discharge, and hospital discharge for both U.S. studies; at ICU awakening, ICU discharge, and hospital discharge for the Australian study; and at ICU admission and ICU discharge for both Brazilian studies.
Well-established measures of physical function, available within the datasets, were used to assess convergent and known-group validity of the FSS-ICU. These measures were the Lawton instrumental Activity of Daily Living (ADL) score (17) (range, 0-8, with higher scores indicating better status), the Katz ADL score (18) (range, 0-6, with higher scores indicating better status), manual muscle testing (MMT, using the Medical Research Council sum score, range, 0-60, with higher scores indicating greater strength, and < 48 indicating ICUacquired weakness [ICUAW] ) (19, 20) , hand grip strength (kg, as percent predicted using normative data [21, 22] ), ICU mobility scale (IMS; range, 0-10, with higher score indicating better mobility) (23), ICU and hospital length of stay (LOS), and hospital discharge location (home vs healthcare facility).
To assess discriminant validity, measures that were available and expected to have little to no relationship with FSS-ICU were used. These included body mass index (BMI), continence status (from ADL scale), hemodialysis status, home oxygen use at hospital discharge, steroid and insulin use on the hospital ward and at hospital discharge.
We used two outcome measures to assess predictive validity of FSS-ICU, similar to prior research (13, (24) (25) (26) : post-ICU hospital LOS (i.e., number of days between ICU and hospital discharge) and hospital discharge location (home vs healthcare facility).
To assess FSS-ICU's responsiveness, changes in FSS-ICU scores across two time points (ICU awakening/admission to ICU discharge, ICU discharge to hospital discharge, and ICU awakening to hospital discharge) were evaluated and were compared with changes across the same two time points for the MMT and ADLs.
Statistical Analysis
Initially, analyses were conducted separately for each dataset and assessment time point to evaluate generalizability of these individual findings by time point, patient sample, and study setting, and then, pooled analyses across studies were performed, whenever feasible and appropriate (i.e., when there were similar results among individual datasets), to increase statistical power. All analyses were performed using Stata 13.1 (Stata, College Station, TX).
Floor and Ceiling Effects
Floor and ceiling effects were evaluated by examining the percentage of assessments with the minimum and maximum FSS-ICU scores, respectively.
Internal Consistency
Pearson correlations were used to identify pairwise correlations between the five FSS-ICU items, and Cronbach α was used to examine the internal consistency of the FSS-ICU total score (27) .
Concurrent Construct Validity
We used Pearson correlations (for continuous measures) and biserial correlations (for binary measures) to examine convergent and discriminant validity. To evaluate convergent validity, we hypothesized that the measures evaluated would be at least moderately correlated (|r| > 0.40) with the FSS-ICU. To evaluate discriminant validity, we hypothesized that measures evaluated would have negligible to weak correlations 55 (16) 54 (15) 58 (17) 66 (10) 75 (9) 70 (13) Men, n (%) 17 (50) 19 (32) 40 (61) 35 (35) 276 (49) 387 (47) Body mass index (kg/m 2 ), mean (sd) 27 (7) 29 (11) 28 (7) 28 (8) ADL score, b mean (sd) 6 (1) 5 (2) 25 (7) 26 (7) 21 (7) 14 (7) 12 (7) 14 (8) ICU admission diagnosis,
Respiratory (including pneumonia)
25 (76) 39 (66) 14 (21) 30 (30) 108 (42) Gastrointestinal 3 (9) 5 (8) 12 (18) 8 (8) 28 (11) Sepsis, nonpulmonary 0 (0) 3 (5) 13 (20) 18 (18) 34 (13) Cardiovascular 2 (6) 4 (7) 18 (27) 10 (10) 34 (13) Trauma 0 (0) 0 (0) 5 (8) 20 (20) 25 (10) Neurologic 0 (0) 4 (7) 0 (0) 13 (13) 17 (7) Other 3 (9) 4 (7) 4 (6) 0 (0) 11 (4) Hospital length of stay, mean (sd)
35 (21) 31 (20) 28 (15) 19 (4) 33 ( (|r| < 0.30). We hypothesized significant negative correlations between FSS-ICU and ICU and hospital LOS. For knowngroup validity, we conducted two-sample t tests for group differences in FSS-ICU by ICUAW status (MMT ≥ 48 vs < 48) and hospital discharge location (home vs healthcare facility). We hypothesized that patients without (vs with) ICUAW or discharged to home (vs healthcare facility) would have significantly higher FSS-ICU scores.
Predictive Validity
As done in prior research (13, 24, 25) , we used two-sample t tests and linear and logistic regression models to test the association of FSS-ICU at ICU discharge with post-ICU hospital LOS and hospital discharge location. In addition, the area under a receiver operating characteristic curve (i.e., C statistic) was calculated for FSS-ICU with discharge location. We hypothesized that patients with higher FSS-ICU scores at ICU This Hodgson ordinal ICU mobility scale evaluates patients' highest mobility level, during physical therapy assessment in the ICU, and ranges from 0 (lying in bed) to 10 (walking independently without a gait aid).
the effect size for changes over time (mean difference in FSS-ICU scores between two time points divided by the sd at first time point) (28) . Third, we evaluated change over time in the FSS-ICU relative to patients' change in MMT and ADL scores, with changes categorized as "significant improvement" if MMT and ADL scores at the later assessment were greater than or equal to 1sd higher than the earlier assessments. A comparison group was comprised of patients whose scores increased less than 1sd or declined over the period (29) .
Estimating MID
We used the following distribution-based methods to estimate MID (30, 31) : sem, minimal detectable change 90 (MDC-90), 0.2sd, and 0.5sd (32) .
RESUlTS

Patient Characteristics
Across the five studies, the mean (sd) age of patients ranged from 54 (15) to 75 (9) years, and the mean (sd) Acute Physiology And Chronic Health Evaluation (APACHE) II score ranged from 12 (7) to 26 (7) ( Table 1 ). Both Brazilian studies had older patients and lower APACHE II scores. There was a wide range of ICU admission diagnoses across the studies, with respiratory failure being the most common primary diagnosis (42% in the combined dataset).
Floor and Ceiling Effect
Minimal floor effect was observed (0.5%, 0.3%, and 0% at ICU admission/awakening, ICU discharge, and hospital discharge, respectively). Some ceiling effect was observed later during recovery (0.7% at ICU admission/awakening and then 11% and 21% at ICU and hospital discharge, respectively).
Internal Consistency
Good to excellent internal consistency was observed (33) . 
Concurrent Construct Validity
Consistently, across studies and time points (Table 2) , we observed significant and positive correlations between FSS-ICU and other physical measures and negative association with ICU and hospital LOS. These findings support concurrent validity. Known-group validity was supported by significantly higher FSS-ICU scores among survivors without ICUAW (MMT ≥ 48 vs < 48) and among those discharged to home (vs healthcare facility) (Web Table 2 , Supplemental Digital Content 2, http://links.lww.com/CCM/B953). Consistent with our hypotheses, most associations were not statistically significant between FSS-ICU and BMI, hemodialysis, need for home oxygen, and steroid and insulin use. These findings support discriminant validity ( Table 2) .
Predictive Validity
We found evidence of predictive validity for duration of post-ICU hospital LOS in the USA-Needham study and in combined results across all studies, with significantly higher FSS-ICU scores at ICU discharge for survivors with below versus above the median post-ICU hospital LOS ( Table 3) . Linear regression analysis suggested that for a 1-unit increase in FSS-ICU score, post-ICU hospital LOS decreased by 0.27 days (p < 0.01) in the combined results (Table 3) . Prediction of discharge location was consistently significant across studies: survivors discharged to home were associated with a higher FSS-ICU at ICU discharge (23 vs 16 in combined results; p < 0.01). Logistic regression indicated that for 1-unit increase in FSS-ICU score, the odds of discharge to home increased by 11% (p < 0.01) in combined results. The C-statistic for discharge location was 0.75 in the combined analysis, indicating that FSS-ICU can adequately predict discharge location. Although not always statistically significant, increased FSS-ICU scores were generally observed with improvements in muscle strength (Table 4) , supporting responsiveness. The effect size was 2.02 from ICU awakening/admission to ICU discharge, suggesting good responsiveness. Only the USA-Kho study, with data on 24-26 patients, could be used to evaluate the FSS-ICU's responsiveness to changes in ADL scores. This study showed a larger increase in FSS-ICU among survivors with more than 1-sd increase in ADL scores compared with those with negative or no change in ADL scores although this difference was significant only when comparing ICU discharge with hospital discharge (Table 4) .
Responsiveness
MID
In the combined results, MID estimates based on the sem and 0.2sd were relatively consistent with 1.2-1.3 for ICU admission/ (15, 22) , and Australia (3, 6). 2) Activities of daily living (ADL) (no change and positive change): ICU awakening to ICU discharge: USA-Kho (2, 22) ; and ICU discharge to hospital discharge: USA-Kho (11, 15) . b The "no change" category represents all patients who did not increase by more than 1 sd at last available FSS-ICU time points; except for Brazil-Neto study, no patient had a decrease in MMT or ADL scores of more than 1 sd. The sd used for different studies: MMT: USA-Kho (7), USA-Needham (10), Australia (6), Brazil-Neto (14), Combined (8); ADL: USA-Kho (3). c p < 0.05 by two-sample t test for comparison of "negative or no change" versus "significant positive change" categories.
d
In Brazil-Neto study, there were patients with significant decrease (> 1sd) of MMT score from ICU admission to ICU discharge, and the change in FSS-ICU in MMT score significant negative change group was 2.9 (n = 22). This is significantly different from the change in FSS-ICU in MMT score no change or positive change groups. e Only one patient was found in this group. awakening, 2.1-2.4 for ICU discharge, and 1.7-1.9 for hospital discharge ( Table 5) . Estimates based on MDC-90 and 0.50sd also were consistent but larger at 3.0-3.1, 5.3-5.4, and 4.3-4.5 for the same time points, respectively. Hence, the MID is estimated to be in the range of 2.0-5.0.
DISCUSSION
Using data from five studies across three continents, we evaluated internal consistency, validity, responsiveness, and MID of FSS-ICU, an outcome measure assessing physical function in critically ill patients (7, 10, 13) . We found consistent and strong evidence of internal consistency and concurrent construct validity with expected findings for convergent, discriminant, and known-group validity tests. The similarity of these clinimetric analyses across individual studies demonstrates generalizability of results and supports pooling of data and analyses across studies, as done in prior research (34) (35) (36) .
The findings of convergent validity between the FSS-ICU and MMT agree with a prior smaller analysis (13) . Prior studies of the FSS-ICU also provided preliminary evidence of predictive validity and responsiveness (10, 13) , which were expanded in our current analyses with larger sample size and more variables. Predictive validity was supported with FSS-ICU scores at ICU discharge significantly predicting post-ICU hospital LOS and hospital discharge location. An increase in FSS-ICU score was observed with improvement in muscle strength and ADLs, and FSS-ICU scores tracked the recovery trajectory of survivors from ICU awakening/admission to hospital discharge with a large effect size, supporting responsiveness. The MID for the FSS-ICU, based on multiple distribution-based methods, is estimated within a range of 2.0-5.0. These results were similar across various time points and the 5 datasets, supporting generalizability.
The results of this evaluation should be compared with similar evaluations of other published ICU-specific physical function measures, including the Physical Function in Intensive care Test scored (PFIT-s) (13, 24, 37) , Chelsea Critical Care Physical Assessment tool (CPAx) (38) (39) (40) , Perme mobility scale (41, 42) , Acute Care Index of Function (ACIF) score (43), Surgical ICU Optimal Mobilization Score (SOMS) (25, 26, 44) , and the IMS (23) . With respect to floor and ceiling effects, for the FSS-ICU, we detected a minimal floor effect (≤ 0.5%), but some ceiling effects at hospital discharge (≤ 21%), which may limit the instrument's ability to detect improvement (45) . However, these findings are favorably comparable with other ICU-specific physical measures (Web Table 3 , Supplemental Digital Content 5, http://links.lww.com/CCM/B956). The CPAx has the lowest ceiling effects at ICU discharge (39, 40) ; however, it is important to note that CPAx differs from other ICU-specific measures (Web Table 3 , Supplemental Digital Content 5, http://links.lww.com/CCM/B956) as it involves evaluation of both physical function (whole body activities and grip strength) and respiratory (ventilation, oxygenation, and secretion clearance) measures. For evaluation of validity, the PFIT-s, IMS, and CPAx also displayed concurrent construct validity with MMT (Web Table 3 , Supplemental Digital Content 5, http://links.lww. com/CCM/B956). Similar to FSS-ICU, PFIT-s also showed construct validity with hand grip strength and IMS, and there is a strong positive correlation between FSS-ICU and PFIT-s (ρ = 0.85-0.87; p < 0.005) at ICU awakening and ICU discharge (13) . Our analyses also demonstrated appropriate divergent validity of FSS-ICU.
For predictive validity, a higher FSS-ICU, along with higher PFIT-s, IMS, SOMS, and ACIF scores, predict shorter hospital LOS and/or discharge location to home. The PFIT-s, IMS, and CPAx also demonstrated moderate to large responsiveness to change via effect-size analyses. Although a prior study of the FSS-ICU demonstrated small responsiveness to change (effect size, 0.46) (13, 24, 37) , our current analysis demonstrated a large effect size (2.02) for FSS-ICU from ICU awakening/ admission to ICU discharge, suggesting good responsiveness.
There is growing interest in identifying a core set of outcome measures, which can be used across the continuum of recovery to measure response to interventions and monitor functional improvement. The FSS-ICU is a robust tool, which can be used to evaluate physical function in both the ICU setting and in the acute hospital setting for ICU survivors. The ability of FSS-ICU to be used in longer term follow-up beyond acute hospitalization may be impacted by a ceiling effect. It is also important to consider clinical utility: the FSS-ICU takes 10 to 30 minutes to complete (depending on patient's functional status), requires no additional equipment, and can be undertaken by the therapist at the bedside with standardized instructions readily available and thus can be easily integrated into routine critical care practice.
The strengths of our study include performing a range of clinimetric analyses using five international datasets with relatively large combined sample size (n = 819). Given that many of our findings were consistent across these datasets with different study designs, patient populations, and time points, generalizability of our findings is supported. However, there are potential limitations. First, we only assessed internal consistency of the FSS-ICU and did not evaluate interrater and testretest reliability, which should be examined in future research. Second, because of the heterogeneity in study design and data collection among studies, some measurements were not available in all studies and at all assessment time points, limiting our sample size for some analyses particularly for analyses of validity and responsiveness, which may have contributed to nonsignificant findings. Third, the Brazil-Neto study evaluated FSS-ICU in Portuguese without undertaking independent forward and backward translation process; however, its results were similar to analyses from the other datasets. Further crosscultural validation is needed. Fourth, we could not calculate the MIDs using an anchor-based method as recommended (30, 31) because of the lack of MIDs for MMT and other available physical measures that would be needed as anchors. However, the sem has been recommended among distribution-based MID methods (31) and estimates based on the SEM converged with those from 0.2sd (31, 46) . Future studies should compare anchor-based MIDs with distribution-based MIDs.
CONClUSIONS
The FSS-ICU is an internally consistent, valid, and responsive measure of physical function in the ICU and acute hospital ward setting. The estimated range for the MID of 2.0-5.0 will facilitate sample size calculations and interpretation of future group comparison studies in ICU patients.
